Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Reparixin for CXCR1/2 Mechanism Studies
2026-09-22
Reparixin is a practical CXCR1/2 inhibitor for separating IL-8 receptor signaling from extracellular-vesicle, tumor-cell, and neutrophil effects. This workflow-focused guide covers fresh-solution handling, chemotaxis and calcium assays, MRSA extracellular-vesicle studies, and translational inflammation models.
-
Octenidine Dihydrochloride Research Workflows
2026-09-22
Build more reliable antimicrobial assays with Octenidine dihydrochloride, from controlled stock preparation and planktonic susceptibility testing to biofilm and structure–activity studies. Practical guidance emphasizes orthogonal readouts, solubility control, and troubleshooting membrane-active assay artifacts.
-
RapaLink-1 Workflows for mTOR Research
2026-09-21
RapaLink-1 is a third-generation mTOR inhibitor for resistance-aware oncology studies and pathway-focused research. This guide translates its bivalent mechanism into glioma assays, mTORC1 inhibition workflows, exploratory dormancy models, and practical troubleshooting steps.
-
Isochlorogenic Acid A Disrupts HBV via HO-1 and ROS
2026-09-21
The reference study shows that isochlorogenic acid A suppresses hepatitis B virus replication through coordinated effects on viral transcription, cccDNA, capsid morphogenesis, envelopment, and intracellular redox balance. Its key contribution is linking HO-1-associated ROS modulation to multiple HBV life-cycle defects rather than treating antiviral activity as a single replication-stage phenomenon.
-
Gemini Quaternary Ammonium Compounds: Study Insights
2026-09-20
The reference study synthesized 16 octenidine-derived gemini quaternary ammonium compounds and identified candidates with broad antibacterial, antibiofilm, antifungal, and virucidal activity. Its structure–activity analysis shows how polarity, membrane interaction, and cytotoxicity can be balanced to improve on conventional disinfectant scaffolds.
-
Pyridostatin TFA: G-Quadruplex Assay Workflows
2026-09-19
Pyridostatin TFA connects structure-focused G-quadruplex assays with cellular studies of telomere dysfunction and cancer cell growth inhibition. This workflow-driven guide also shows how to interpret emerging RNA G-quadruplex and TDP-43 findings without overextending DNA-focused evidence.
-
GSK 2837808A LDHA Workflow for Cancer Research
2026-09-18
GSK 2837808A is a potent lactate dehydrogenase A inhibitor for separating LDHA-dependent lactate flux from broader glycolytic effects. This practical workflow connects validated hepatocellular carcinoma use with hypothesis-driven cancer metabolism research on the NAT1–ENO1–lactate axis in colorectal cancer.
-
(5Z)-7-Oxozeaenol: TAK1 Inhibitor Workflows
2026-09-18
Build reproducible assays that connect IL-1-stimulated TAK1 activity with NF-κB, JNK/p38 MAPK, and COX-2 responses. This workflow also extends into metabolic-stress experiments, where TAK1 inhibition can help test the AMPK–SQSTM1/p62–NRF2 feedback circuit without overinterpreting pathway-level effects.
-
L-Alanyl-L-Glutamine: Protocol and QC Guide
2026-09-17
L-Alanyl-L-glutamine (SKU B8228) provides a water-soluble L-Ala-L-Gln dipeptide for controlled nutritional, gastrointestinal, and barrier-function workflows. It is suited to aqueous preparations and should not be used in DMSO or ethanol, stored as a long-term solution, or treated as a substitute for chemically distinct glutamine analogs.
-
Haloprogin: Findings from a 1970 Antifungal Study
2026-09-17
The 1970 reference study established Haloprogin as a topical agent with dermatophyte activity comparable to tolnaftate, while also showing activity against Candida-like yeasts and selected Gram-positive bacteria. Its value lies in the paired broth, fungicidal, formulation, and guinea pig infection experiments that connected in vitro spectrum with topical performance.
-
Exemestane in Aromatase Assay Workflows
2026-09-16
Build more interpretable estrogen biosynthesis assays with Exemestane, an irreversible steroidal aromatase inhibitor designed for enzyme, microsome, and hormone-dependent cell models. This workflow-focused guide connects dose planning, washout experiments, orthogonal readouts, and troubleshooting to practical breast cancer research decisions.
-
Tricine-SDS-PAGE Gel Preparation Kit Guide
2026-09-16
The Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit is intended to improve resolution of low-molecular-weight proteins and peptides that are difficult to separate with conventional Tris-SDS-PAGE. It is suitable for controlled research protein electrophoresis, including denaturing and non-denaturing workflows when compatible sample and running conditions are used, but it is not intended for diagnostic or medical applications.
-
Gemini Quaternary Ammonium Compounds: Study Insights
2026-09-15
The reference study describes 16 novel gemini quaternary ammonium compounds designed to address limitations associated with conventional disinfectants, including solubility, cytotoxicity, and incomplete activity across microbial classes. Its integrated synthesis, in silico screening, antibacterial, biofilm, antifungal, virucidal, and cytotoxicity evaluation identifies several promising leads, particularly compounds 1 and 12, while also defining important limits for translation.
-
Phosbind Acrylamide: Read Phosphorylation in Gels
2026-09-15
Phosbind Acrylamide enables antibody-independent phosphorylation analysis by converting phosphate-dependent interactions into SDS-PAGE mobility shifts. This guide explains how to interpret those shifts, design controls, and connect gel-based evidence to causal protein phosphorylation signaling studies.
-
NAT1–ENO1–Lactate Axis in Colorectal Cancer
2026-09-14
A 2026 MedComm study identifies NAT1 as a metabolic–immune regulator in colorectal cancer, showing that NAT1 restrains ENO1 activity and lactate production while limiting TRAF6-dependent PD-L1 stabilization. Its integrated database, multi-omics, cellular, patient, and mouse-model evidence provides a mechanistic framework for testing lactate-pathway perturbation alongside immune checkpoint blockade.